Abstract

Tetramethyl thiuram disulphide (Thiram, TMTD), a mutagen, is analysed for its clastogenic property by using micronuclei induction studies in the bone marrow of erythrocytes of male Swiss albino mice. Three concentrations of TMTD, i.e. 100, 150 and 200 mg/kg body wt did not significantly increase the micronuclei in polychromatic erythrocytes or the ratio of poly-to normochromatic erythrocytes. The tumour initiating (10 mg and 1 mg each in 0.2 ml DMSO) and promoting (1 mg in 0.2 ml DMSO) potency of TMTD were tested in female Swiss mice by two stage skin carcinogenic model. There was no significant increase in tumours in the TMTD treated groups, either as initiator or promoter. The results indicated nonclastogenicity and non-carcinogenicity of TMTD under these experimental conditions.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.